Back

Reach out

Please select an option

Please select an option

Please enter a valid email address

Please complete this field

400 characters limit

Please complete this field

400 characters limit

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • Stage
  • Sector
  • Year founded
  • Web Site
  • Managers
  • Social Media

Related Content

We make UCL’s research physical and life sciences ideas happen.

Portfolio

Discover companies, licensing projects and proof-of-concepts backed by the Fund across Life Sciences and Physical Sciences. (Here listed only the publicly announced investments)

Filter

Investment type

Stage

  • 0 1 Achilles TX

    Biotech company developing novel cancer immunotherapies

  • 0 2 Apollo Therapeutics Limited

    Biotech company advancing a broad pipeline of potentially transformative therapeutic programs

  • 0 3 ATTR

    Developing small molecule stabilisers to stabilise transthyretin in a rare, progressive disease called ATTR

  • 0 4 Bloomsbury AI

    Acquired company that created natural language processing technology to help machines answer questions.

  • 0 5 Bloomsbury Genetic Therapies

    Biotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases

  • 0 6 Bramble Energy

    Fuel cell company on a mission to help the world achieve net zero

  • 0 7 Carbon Re

    Climate tech company using AI solutions to decarbonise cement and steel

  • 0 8 Cell therapy for glaucoma

    Allogeneic stem cell derived therapy for the treatment of glaucoma

  • 0 9 Echopoint

    Medtech company developing, manufacturing and commercialising cardiovascular devices

  • 10 Epsilogen

    Biotech company developing immunoglobulin E (IgE) antibodies to treat cancer

  • 11 Spur Therapeutics

    Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechnology company focused on developing life-changing gene therapies for debilitating chronic conditions.

  • 12 Gaussion

    Company inventing and developing fast-charging batteries

  • 13 Glialign

    Cell therapy for peripheral nerve repair

  • 14 GQ Targeting

    Novel drugs for the treatment of pancreatic cancer – partnered with Qualigen Therapeutics

  • 15 Hazy

    AI company aiming to help developers and data scientists share information securely

  • 16 Horizontal Cells Gene Therapy

    Gene therapy targeting novel circuity for degenerative retinal diseases.

  • 17 Humanloop

    AI company creating tools allowing businesses to integrate natural language processing (NLP)

  • 18 Intrinsic Semiconductor Technologies

    Develops a new type of all-silicon non-volatile memory

  • 19 KIT-AR

    Augmented worker platform focused on improving quality and efficiency in production lines

  • 20 MeiraGTx

    Clinical-stage gene therapy company developing treatments for ocular diseases, NASDAQ: MGTX

  • 21 NovalGen

    Clinical-stage company developing autoregulatory bispecific antibody therapies to fight cancer

  • 22 Nozzle.AI

    (Formerly Mediagamma) AI-powered eCommerce and advertising optimisation platform for Amazon

  • 23 Odin Vision

    Company using AI to improve endoscopic procedures for better early detection and diagnosis of cancer

  • 24 OPS-γδ

    Engineered gamma delta (γδ) T cell platform for solid tumours.

  • 25 Orchard Therapeutics

    Ex vivo lentiviral gene therapy company providing curative treatment for devastating inherited diseases, NASDAQ: ORTX

  • 26 Oriole Networks

    UCL spinout using light to train LLMs a hundred times faster with only a fraction of power

  • 27 Pometry

    Software company simplifying graph analytics for businesses

  • 28 Phasecraft

    Quantum computing company developing novel techniques to deliver real-world applications

  • 29 SenyaTx

    Targeting LRG1 as a pathological regulator in a range of vascular diseases

  • 30 Stanhope AI

    AI startup leveraging active inference and the free energy principle to build ‘Agentic AI’ for the real world.

  • 31 Quell Therapeutics

    Developing cell therapy treatments for organ transplant patients and people with auto-immune conditions

  • 32 Third Space Learning

    EdTech platform connecting online maths tutors with pupils

  • 33 Transthyretin stabiliser project

    Small molecule super-stabilisers of transthyretin for disease-modifying therapy in ATTR

Featured Investments

Latest news and views from the team, companies and the UCL ecosystem.

 

Let’s talk

UCLTF offers investment throughout the commercialisation journey. We fund proof-of-concept and development projects, and support founding teams with company formation.

Learn more